Pittsburgh Life Sciences Greenhouse
63
1M
38
2.86
11
0.40
5
- Stages of investment
- Areas of investment
Summary
Pittsburgh Life Sciences Greenhouse is the famous VC, which was founded in 2001. The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the Pittsburgh.
The overall number of key employees were 6.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Pittsburgh Life Sciences Greenhouse, startups are often financed by Ben Franklin Technology Partners of Northeastern Pennsylvania, Ogden Capital, Novitas Capital. The meaningful sponsors for the fund in investment in the same round are BlueTree Allied Angels, Accelerator Fund, Harbor Light Capital Partners. In the next rounds fund is usually obtained by Ben Franklin Technology Partners of Northeastern Pennsylvania, BlueTree Allied Angels, Accelerator Fund.
The fund is generally included in 2-6 deals every year. Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 1 - 5 millions dollars. The high activity for fund was in 2010. Despite it in 2019 the fund had an activity. The increased amount of exits for fund were in 2010. This Pittsburgh Life Sciences Greenhouse works on 23 percentage points less the average amount of lead investments comparing to the other organizations. The average startup value when the investment from Pittsburgh Life Sciences Greenhouse is 10-50 millions dollars.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Biotechnology, Health Diagnostics. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Medrobotics, Saladax Biomedical, Cognition Therapeutics.
Investments analytics
Analytics
- Total investments
- 63
- Lead investments
- 11
- Exits
- 5
- Rounds per year
- 2.86
- Follow on index
- 0.40
- Investments by industry
- Biotechnology (43)
- Health Care (36)
- Medical Device (22)
- Therapeutics (17)
- Life Science (14) Show 32 more
- Investments by region
- United States (62)
- Sweden (1)
- Peak activity year
- 2010
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 17
- Avg. valuation at time of investment
- 8M
- Group Appearance index
- 0.48
- Avg. company exit year
- 10
- Avg. multiplicator
- 4.33
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Cognition Therapeutics | 16 Jul 2009 | Biotechnology, Life Science, Therapeutics | Early Stage Venture | 1M | United States, Pennsylvania, Pittsburgh |
| Complexa | 11 Oct 2013 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | 200K | United States, Pennsylvania, Pittsburgh |
| Flodesign Sonics | 11 Jan 2018 | Biotechnology, Manufacturing, Life Science, Chemical | Early Stage Venture | 0 | United States, Massachusetts |
| Forage Hyperfoods Inc. | 01 Aug 2021 | Food and Beverage | Early Stage Venture | 1M | Ontario, Ottawa, Canada |
| Sensus AI | 06 Dec 2022 | Seed | 295K |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.